Charles Qin, MD
Orthopaedic Surgery · Keene, NHNPI 1386037943
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.8%), grants and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Arthrex at 43.4% of the total. Reporting peaked in 2023 at $31,042 and has fallen 98.6% since, to $438 in 2025.
Across 62 payments — averaging $743.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$19K
- Stryker$3K
- CDC Medical LLC$2K
- Medacta USA, Inc.$1K
- Vericel Corporation$270
- plus $723 from 10 others
Across 2 payments — averaging $1783.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$4K
What the payments were for
- Grants$20,00043%
- Travel & lodging$2,0995%
- Food & beverage$3,3197%
- Education$20,65545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $20,000 |
| Smith+Nephew | 7 | $18,520 |
| Stryker | 28 | $2,983 |
| CDC Medical LLC | 2 | $2,400 |
| Medacta USA, Inc. | 5 | $1,177 |
| Vericel Corporation | 4 | $270 |
| Moximed, Inc | 4 | $210 |
| Zimmer Biomet | 1 | $135 |
| Novo Nordisk | 1 | $122 |
| Acumed LLC | 1 | $98 |
| Johnson & Johnson | 3 | $50 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| Trimed, Inc. | 1 | $26 |
| Checkpoint Surgical, Inc | 1 | $18 |
| Medical Device Business Services, Inc. | 1 | $17 |
| Kairos Surgical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,477
- AMIStem H Femoral Stems$635
- Shoulder System$542
- T2$386
- GAMMA$257
- MISHA KNEE SYSTEM, SMALL, LEFT$143
- INTERMAXILLARY FIXATION$141
- TAPESTRY$135
- Ozempic$122
- Bioinductive Implant with Arthroscopic Delivery System - Medium$110
- MACI$110
- Bone Anchors with Arthroscopic Delivery System$108
- AUGMENT INJECTABLE$101
How this compares
$46,073 in reported general payments places this provider in the 85th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 126 | $307 |
| Methylprednisolone | 14 | $127 |
| Celecoxib | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Keene
- Mia QinKeene$22K
- Vivek VenugopalKeene$18K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
- David RichardsNashua$122K
- Philip WolinskyLebanon$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.